Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT 3rd.
Logigian EL, et al. Among authors: dilek n.
Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a.
Neurology. 2010.
PMID: 20439846
Free PMC article.
Clinical Trial.